Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001
Titel:
Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001
Auteur:
Paz-Ares, L. Doebele, R.C. Farago, A.F. Liu, S.V. Chawla, S.P. Tosi, D. Blakely, C.M. Krauss, J.C. Sigal, D. Bazhenova, L. John, T. Besse, B. Wolf, J. Seto, T. Chow-Maneval, E. Ye, C. Simmons, B. Demetri, G.D.